These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21796479)

  • 21. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics.
    Riquelme A; Arrese M; Soza A; Morales A; Baudrand R; Pérez-Ayuso RM; González R; Alvarez M; Hernández V; García-Zattera MJ; Otarola F; Medina B; Rigotti A; Miquel JF; Marshall G; Nervi F
    Liver Int; 2009 Jan; 29(1):82-8. PubMed ID: 18647235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
    El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
    Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?
    Fu JF; Shi HB; Liu LR; Jiang P; Liang L; Wang CL; Liu XY
    World J Gastroenterol; 2011 Feb; 17(6):735-42. PubMed ID: 21390143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
    Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
    Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures.
    Alavian SM; Mohammad-Alizadeh AH; Esna-Ashari F; Ardalan G; Hajarizadeh B
    Liver Int; 2009 Feb; 29(2):159-63. PubMed ID: 18492015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia.
    Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1375-83. PubMed ID: 23517307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides.
    Kallwitz ER; Kumar M; Aggarwal R; Berger R; Layden-Almer J; Gupta N; Cotler SJ
    Dig Dis Sci; 2008 May; 53(5):1358-63. PubMed ID: 18347982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; de la Fuente B; Perez Castrillon JL
    Eur Rev Med Pharmacol Sci; 2009; 13(6):413-8. PubMed ID: 20085121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease.
    Ghamar-Chehreh ME; Amini M; Khedmat H; Moayed Alavian S; Daraei F; Mohtashami R; Hadi R; Beyram BA; Taheri S
    Asian Pac J Trop Biomed; 2012 Sep; 2(9):702-6. PubMed ID: 23569998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community.
    Rajindrajith S; Pathmeswaran A; Jayasinghe C; Kottahachchi D; Kasturiratne A; de Silva ST; Niriella MA; Dassanayake AS; de Silva AP; de Silva HJ
    BMC Gastroenterol; 2017 Nov; 17(1):135. PubMed ID: 29187144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease.
    Pirgon Ö; Bilgin H; Çekmez F; Kurku H; Dündar BN
    J Clin Res Pediatr Endocrinol; 2013; 5(1):33-9. PubMed ID: 23367495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of insulin resistance in obese patients on elevated serum alanine aminotransferase.
    De Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; Gonzalez Hernandez JM
    Eur Rev Med Pharmacol Sci; 2007; 11(1):21-5. PubMed ID: 17405346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children.
    Gupta R; Bhangoo A; Matthews NA; Anhalt H; Matta Y; Lamichhane B; Malik S; Narwal S; Wetzler G; Ten S
    J Pediatr Endocrinol Metab; 2011; 24(11-12):907-11. PubMed ID: 22308841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase.
    López-Suárez A; Guerrero JM; Elvira-González J; Beltrán-Robles M; Cañas-Hormigo F; Bascuñana-Quirell A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1011-7. PubMed ID: 21915061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension.
    Fallo F; Dalla Pozza A; Sonino N; Lupia M; Tona F; Federspil G; Ermani M; Catena C; Soardo G; Di Piazza L; Bernardi S; Bertolotto M; Pinamonti B; Fabris B; Sechi LA
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):646-53. PubMed ID: 19278843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
    Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
    Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.